๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma

โœ Scribed by Tohru Utsunomiya; Mitsuo Shimada; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Masaki Mori

Publisher
Springer Japan
Year
2009
Tongue
English
Weight
371 KB
Volume
45
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Predicting the risk of tumor recurrence
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma
โœ J W Marsh; A Casavilla; S Iwatsuki; I Dvorchik; M Subotin; V Balan; J Rakela; V ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 1 views

be either higher or lower than 1, i.e., having serological mark-to the exposure of interest, constitute a valid and well-accepted comparison group, which has been used in countless ers of infection by hepatitis B and C viruses could be either ''protective'' or ''predisposing'' factors for aplastic a

Can the prognosis of liver transplantati
Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
โœ B Ringe ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 1 views

Slow-growing tumors have the best prognosis. It is increasingly clear that hepatitis B and C play a role in the develop-Hepatocellular carcinoma (HCC), one of the most frequent ment and progression of HCC both before and after liver malignant tumors in the world, can be fatal if untreated. transplan

Can determination of the proliferative c
Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
โœ Jen-Hwey Chiu; Li-Hwa Wu; Hwa-Li Kao; Hwey-May Chang; Shyh-Haw Tsay; Che-Chuan L ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 589 KB

## Republic of China To test the hypothesis that increased proliferative capacity of cells in a liver remnant is a risk factor for tumor recurrence in patients who have undergone liver resection for hepatocellular carcinoma, DNA flow-cytometric measurement and cell-cycle analysis of the nontumor p

The prediction of risk of recurrence and
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study
โœ J W Marsh; I Dvorchik; M Subotin; V Balan; J Rakela; E P Popechitelev; V Subboti ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 198 KB ๐Ÿ‘ 1 views

Orthotopic liver transplantation (OLTx) in the presence of hepatocellular carcinoma (HCC) has been complicated by high recurrence rates. The ability to determine the risk and timing of HCC recurrence on an individual basis would greatly aid in the candidate selection process resulting in a more effi